NGM Biopharmaceuticals agrees to $135 million buyout

Published on 25 Feb 2024 on Investing.com

NGM Biopharmaceuticals , Inc. (NASDAQ: NGM ), a biotech firm engaged in developing transformative therapeutics, is set to be acquired ...

Read the rest of the article

Start tracking your investments with Statfolio

Jin-Long Chen knows the biotech cycle of life, maybe too well. Chen last year left NGM ...

The Business Journals 12 Mar 2024

Affiliates of NGM Biopharmaceuticals Inc. earliest venture capital backer and its largest current...

The Business Journals 26 Feb 2024

Shares of Freshpet, Inc. FRPT gained 15.5% to $106.29 after the company reported better-than-exp...

Benzinga 26 Feb 2024

NGM Biopharmaceuticals , Inc. (NASDAQ: NGM ), a biotech firm engaged in developing transformative...

Investing.com 25 Feb 2024

Key Insights Given the large stake in the stock by institutions, NGM Biopharmaceuticals' stock pr...

Simply Wall St. via Yahoo Finance 3 Jan 2024

NGM Biopharmaceuticals Inc (NASDAQ:NGM) reported a net loss of $28.8 million for Q3 2023, compare...

GuruFocus.com via Yahoo Finance 3 Nov 2023

Insiders who acquired US$462k worth of NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) stock at an av...

Simply Wall St. via Yahoo Finance 24 Sep 2023

One thing we could say about the analysts on NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) - they are...

Simply Wall St. via Yahoo Finance 8 Aug 2023

Key Insights Significantly high institutional ownership implies NGM Biopharmaceuticals' stock pri...

Simply Wall St. via Yahoo Finance 27 Jul 2023

You may think that with a price-to-sales (or "P/S") ratio of 5.8x NGM Biopharmaceuticals, Inc. (N...

Simply Wall St. via Yahoo Finance 5 May 2023